KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Shares Issued (2021 - 2025)

QuidelOrtho's Shares Issued history spans 5 years, with the latest figure at $100000.0 for Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $100000.0; the TTM value through Dec 2025 reached $6.1 million, up 22.0%, while the annual FY2025 figure was $6.1 million, 22.0% up from the prior year.
  • Shares Issued for Q4 2025 was $100000.0 at QuidelOrtho, down from $2.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $19.1 million in Q1 2023 and bottomed at $100000.0 in Q2 2025.
  • The 5-year median for Shares Issued is $2.6 million (2021), against an average of $3.4 million.
  • The largest YoY upside for Shares Issued was 625.0% in 2025 against a maximum downside of 97.56% in 2025.
  • A 5-year view of Shares Issued shows it stood at $2.4 million in 2021, then surged by 45.83% to $3.5 million in 2022, then changed by 0.0% to $3.5 million in 2023, then plummeted by 88.57% to $400000.0 in 2024, then crashed by 75.0% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Shares Issued are $100000.0 (Q4 2025), $2.9 million (Q3 2025), and $100000.0 (Q2 2025).